A5006322972- Liver Disease Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis B Virus Studies
- Clinical Reasoning and Diagnostic Skills
- Drug Transport and Resistance Mechanisms
- Innovations in Medical Education
- Radiology practices and education
- Ovarian cancer diagnosis and treatment
- MRI in cancer diagnosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
Hôpital Beaujon
2021-2024
Assistance Publique – Hôpitaux de Paris
2021-2024
Hôpital Bichat-Claude-Bernard
2022
Aims According to the last WHO classification, steatohepatitic hepatocellular carcinoma (SH‐HCC) is recognized as a distinct HCC subtype, even though consensual definition still lacking. The objectives of study were carefully describe morphological features SH‐HCC and evaluate its impact on prognosis. Methods results We conducted single‐centre retrospective including 297 surgically resected HCC. Pathological SH criteria (steatosis, ballooning, Mallory–Denk bodies, fibrosis, inflammation)...
Abstract According to the WHO, steatohepatitic hepatocellular carcinoma (SH-HCC) is a distinct HCC subtype. Its prevalence and prognosis vary depending on study, probably because of lack consensus pathological definition. The objectives study were carefully describe morphological features SH-HCC propose relevant definition evaluate its impact prognosis. We conducted single-centre retrospective including 297 surgically resected HCC. Pathological tumor SH criteria (steatosis, ballooning,...